CD274 and cancer: Lower scores were associated with longer survival on anti-PD-1/PD-L1 monotherapy (Fig. 2F), but poorer survival on docetaxel and prognosis in The Cancer Genomic Atlas (TCGA)-LUAD cohort (Supplementary Fig. 4).